ZSANのチャート
ZSANの企業情報
| symbol | ZSAN |
|---|---|
| 会社名 | Zosano Pharma Corp （ゾサノ・ファ―マ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 ゾサノ・ファーマー（Zosano Pharma Corporation）は臨床段階の特殊医薬品会社。同社は、各種適応症の治療のために皮膚を介して既存の薬物のその製剤を提供するために、経皮マイクロニードルパッチシステムを開発した。そのマイクロニードルパッチシステムは、商業市場におけるさまざまな適応症の多数の薬物を送達する可能性を有する。その短い摩耗時の経皮パッチは、既存の薬物のその処方でコーティングし、接着剤のパッチに添付されたチタンマイクロニードルの配列で構成されます。同社のリード製品候補とその扱い適応症は、重度の骨粗しょう症のためのWeekly ZP-PTH、重度の低血糖のためのZP-Glucagon、片頭痛のためのZP-Triptanを含む。平成26年1月、同社はマイクロニードルパッチ製品を開発ために、Novo Nordisk A/S (Novo Nordisk)と戦略的パートナーシップおよびライセンス契約を締結した。 ゾサノ・ファ―マは米国の臨床段階の医薬品会社。治療薬物を多数の微小突起を介して皮膚表皮に浸透させることによる、経皮的微小突起薬物送達システムを開発。このシステムを利用した経皮製剤は、薬物が被覆された微小突起が配置された薄膜(アレイ)が装着された粘着性パッチと、再利用可能なアプリケ―タから構成される。本社はカリフォルニア州。 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine. |
| 本社所在地 | 34790 Ardentech Court Fremont CA 94555 USA |
| 代表者氏名 | John P. Walker ジョンP.ウォーカー |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 510-745-1200 |
| 設立年月日 | 40909 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2015年 |
| 従業員数 | 38人 |
| url | www.zosanopharma.com |
| nasdaq_url | https://www.nasdaq.com/symbol/zsan |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -30.20100 |
| 終値（lastsale） | 4.16 |
| 時価総額（marketcap） | 49807842.24 |
| 時価総額 | 時価総額（百万ドル） 47.05404 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 13.01604 |
| 当期純利益 | 当期純利益（百万ドル） -32.40400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Zosano Pharma Corp revenues was not reported. Net loss increased 24% to $17M. Higher net loss reflects Other income decrease of 70% to $3K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$9.22 to -$4.91. |
ZSANのテクニカル分析
ZSANのニュース
Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? 2022/06/07 11:00:00 Stocks Register
Zosano Pharma Corporation (NASDAQ:ZSAN) traded at $0.56 at close of the session on Monday, 06/06/22, made a downward move of -27.56% on its previous day’s price. Looking at the stock we see that its previous close was $0.78 and the beta (5Y monthly) reads 3.29 with the day’s price range being $0.565 – $0.72. In … Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? Read More »
Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? 2022/06/07 11:00:00 Stocks Register
Zosano Pharma Corporation (NASDAQ:ZSAN) traded at $0.56 at close of the session on Monday, 06/06/22, made a downward move of -27.56% on its previous day’s price. Looking at the stock we see that its previous close was $0.78 and the beta (5Y monthly) reads 3.29 with the day’s price range being $0.565 – $0.72. In … Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? Read More »
Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? 2022/06/07 11:00:00 Stocks Register
Zosano Pharma Corporation (NASDAQ:ZSAN) traded at $0.56 at close of the session on Monday, 06/06/22, made a downward move of -27.56% on its previous day’s price. Looking at the stock we see that its previous close was $0.78 and the beta (5Y monthly) reads 3.29 with the day’s price range being $0.565 – $0.72. In … Zosano Pharma Corporation (NASDAQ: ZSAN) Is Down -27.56% – Is It Capable Of A Rally? Read More »
ADAP, SLDP and ZSAN among mid-day movers 2022/06/03 16:42:11 Seeking Alpha
Gainers: Turning Point Therapeutics TPTX +117%.Energy Focus EFOI +40%.Galecto GLTO +25%.Adaptimmune (ADAP) +22%.Amylyx Pharmaceuticals AMLX +22%.AudioEye AEYE +20%.Sprague Resources…
US stocks closed higher, Dow Jones up 1.33% 2022/06/03 03:12:40 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 1.33%, the S&P 500 rose 1.84% and the NASDAQ Composite index rose 2.69%. Boeing Co was the top gainer among the components of the Dow Jones in today''s trading, up 9.85 points or 7.54% to close at 140.50. Salesforce.com Inc rose 12.33 points or 7.00% to close at 188.40. Nike Inc rose 4.73 points or 3.99% to close at 123.41. The biggest losers were Amgen Inc, which shed 5.14 points or 2.03% to end the session at 248.28. Merck & Company Inc. shares rose 1.14 points (1.25%) to close at 90.00, while Johnson & Johnson shed 0.56 points (0.32%) to close at 177.15. The leaders of gains among the components of the S&P 500 in today''s trading were General Holdings Inc, which rose 10.29% to 268.95, SolarEdge Technologies Inc, which gained 10.28% to close at 300.49, and also shares of DexCom Inc, which rose 9.86% to end the session at 311.83. The biggest losers were Hormel Foods Corporation, which shed 5.22% to close at 45.76. Shares of Hewlett Packard Enterprise Co lost 5.20% to end the session at 14.96.
Why Zosano Pharma Shares Are Getting Hammered Today 2022/06/02 18:42:03 Benzinga
Zosano Pharma Corp (NASDAQ: ZSAN ) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11. Zosano says the company continues to operate its business as a "debtor-in-possession" under the … Full story available on Benzinga.com